Indiana Medicaid and GLP-1s
You do not have to read Indiana's criteria to find the rule; it is in the headings. The Zepbound chapter and the Wegovy chapter are each titled with a parenthesis saying the drug is not covered exclusively for weight loss. Underneath, the routes are sleep apnea and cardiovascular disease. A 2023 bulletin, still listed among current bulletins, opens a narrower door for children.
What changed, and what the document says
The Zepbound chapter says it in its title
Not coveredA heading is a strange place to put a coverage limit, and it is the clearest statement in the document.
“ZEPBOUND (TIRZEPATIDE) (NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS)”
Prepared for State of Indiana by OptumRx — 10.01.2025
So does the Wegovy chapter
Not coveredThe same construction, repeated, so neither reads as a one-off.
“WEGOVY (SEMAGLUTIDE) (NOT COVERED EXCLUSIVELY FOR WEIGHT LOSS)”
Prepared for State of Indiana by OptumRx — 10.01.2025
The rule has a code section behind it
Not coveredIndiana's pharmacy manual reproduces the administrative rule that excludes the category, so the criteria are downstream of a regulation.
“Anorectics or any agent used to promote weight loss.”
Indiana Health Coverage Programs (IHCP) — Published: Aug. 12, 2025; policies and procedures as of Feb. 1, 2025; Version 8.0
Children have a separate, older route
CoveredA bulletin that is still in the published index names two drugs available to eligible children with authorization.
“Wegovy (semaglutide) and Saxenda (liraglutide)”
Indiana Health Coverage Programs — IHCP bulletin BT2023148 — October 31, 2023
Reviewed twice a year
Conditions applyThe children's route is not open-ended; it is re-tested on a fixed cycle.
“Reassessments of medical necessity for continued authorization will occur every six months.”
Indiana Health Coverage Programs — IHCP bulletin BT2023148 — October 31, 2023
Who wrote the criteria
ContextWorth knowing when you read them: the document is authored by the state's pharmacy benefit manager on the state's behalf, and says so on its first page.
“Prepared for State of Indiana by OptumRx”
Prepared for State of Indiana by OptumRx — 10.01.2025
Which of these companies serve Indiana?
Of the 242 companies we grade, 25 publish a list of the states they are licensed in. We checked 214 more and found no such list on any page we read; 3 we have not checked either way.
18 of those lists name Indiana: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Willow, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon and Peak Wellness. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Sources
Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026, the same session as the rest of this page.
- Criteria for Indiana Medicaid — GLP-1 Receptor Agonists and Combinations — Prepared for State of Indiana by OptumRx. Printed in the footer of every page; the document prints no other date: 10.01.2025.
- Pharmacy Services — IHCP provider reference module — Indiana Health Coverage Programs (IHCP). Publication date, policy-currency date and version, all printed on the cover: Published: Aug. 12, 2025; policies and procedures as of Feb. 1, 2025; Version 8.0.
- IHCP to cover weight-loss medications in select cases under EPSDT — Indiana Health Coverage Programs — IHCP bulletin BT2023148. Printed in the masthead beside the bulletin number: October 31, 2023.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
None of the above changes what a telehealth seller charges you. 1 of these 3 bills a fee every month on top of the medication, so the figure is the two added together. The other 2 say in the cell what we could capture and what we could not. Every number was read on the seller's own page; the adding up is ours.
QuickMD, Hello Alpha and Medi-Weightloss pay us nothing — none of the 3 below does. The buttons run through our own redirect so we can count the click, and counting is all they do.
| Grade | Provider | What a month actually costs | The one thing that matters here | Go to the provider |
|---|---|---|---|---|
| BMinor gap | QuickMD | No month-to-month medication price we could capture, so there is no monthly total to show.Charged per visit rather than every month, so it is not in the figure above: $99 for weight loss visit.The review says what else we found. | A $99 weight-loss visit and nothing bundled, which is the cheapest way to find out whether a sleep-apnea or cardiovascular route is even open to you. | See its prices at QuickMD (opens in a new tab)Pays us nothing |
| CCaveat | Hello Alpha | No month-to-month medication price we could capture, so there is no monthly total to show.What they do bill every month: $79 a month for Plus+ membership, $29 a month for Basic membership.The review says what else we found. | Runs on membership tiers at $29 and $79 rather than a drug price, so the medication cost sits on top — worth knowing before comparing it to a benefit with no copay at all. | See its prices at Hello Alpha (opens in a new tab)Pays us nothing |
| CCaveat | Medi-Weightloss | $248a month, everything billed monthly$99 compounded semaglutide, first month + $149 a month for hormone optimization membershipThe only recurring monthly figure published anywhere on this company's site.The only figure published for this drug. No second-month rate appears on any page we read.The lowest of the 2 medication prices we captured hereCharged per visit rather than every month, so it is not in the figure above: $199 for new patient visit, $50 for visit cost with insurance, $49 for hormone optimization screener lab, $149 for hormone optimization full panel labs. | Prices a first month of compounded semaglutide at $99 and tirzepatide at $199, plus a $199 new-patient visit, so the first month and the months after are different numbers. | See its prices at Medi-Weightloss (opens in a new tab)Pays us nothing |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.